IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FRASCHINI, FRANCO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.073
NA - Nord America 3.973
AS - Asia 3.924
SA - Sud America 312
AF - Africa 103
OC - Oceania 19
Totale 13.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.763
GB - Regno Unito 1.996
SG - Singapore 1.246
CN - Cina 1.218
IT - Italia 667
SE - Svezia 556
RU - Federazione Russa 448
DE - Germania 399
HK - Hong Kong 382
VN - Vietnam 287
FR - Francia 225
IN - India 200
BR - Brasile 195
IE - Irlanda 173
CA - Canada 165
KR - Corea 161
TR - Turchia 161
NL - Olanda 159
UA - Ucraina 158
FI - Finlandia 106
EU - Europa 81
BD - Bangladesh 63
GR - Grecia 49
CI - Costa d'Avorio 47
CO - Colombia 47
JP - Giappone 43
ID - Indonesia 27
MX - Messico 25
PL - Polonia 24
IQ - Iraq 21
BE - Belgio 20
PH - Filippine 20
AR - Argentina 18
AU - Australia 17
ES - Italia 15
CH - Svizzera 12
EC - Ecuador 12
PK - Pakistan 12
ZA - Sudafrica 12
CL - Cile 11
RO - Romania 11
TN - Tunisia 10
PY - Paraguay 9
VE - Venezuela 9
AT - Austria 8
HU - Ungheria 8
MY - Malesia 8
PE - Perù 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
KE - Kenya 7
EG - Egitto 6
IL - Israele 6
JM - Giamaica 6
KZ - Kazakistan 6
TH - Thailandia 6
BG - Bulgaria 5
JO - Giordania 5
MA - Marocco 5
OM - Oman 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
ET - Etiopia 4
LU - Lussemburgo 4
NP - Nepal 4
BB - Barbados 3
EE - Estonia 3
GE - Georgia 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CD - Congo 1
DO - Repubblica Dominicana 1
GM - Gambi 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
Totale 13.476
Salva come PNG Salva come JPEG
Città #
Southend 1.847
Singapore 703
Hong Kong 362
Chandler 318
Ashburn 280
Beijing 272
Milan 239
San Jose 235
Seattle 229
Dallas 201
Princeton 188
Dublin 173
Wilmington 137
Los Angeles 132
Council Bluffs 129
Jacksonville 106
Santa Clara 104
Ann Arbor 102
Bengaluru 92
Redmond 90
Toronto 82
Dearborn 76
Mountain View 76
Lauterbourg 72
New York 72
Hanoi 67
Nanjing 63
Buffalo 59
Ho Chi Minh City 59
Des Moines 57
Shanghai 56
Sakarya 55
Boardman 52
Jinan 50
Somerville 50
Guangzhou 49
Abidjan 47
Athens 47
Serra 46
The Dalles 43
Andover 40
Moscow 40
Bogotá 39
Shenyang 38
Munich 37
Frankfurt am Main 35
Hanover 35
Ottawa 35
Houston 34
Columbus 33
Woodbridge 33
Tokyo 32
Tianjin 31
Nanchang 30
Changsha 29
London 29
Dong Ket 28
Hebei 28
Eitensheim 27
Phoenix 25
Fairfield 24
Falls Church 24
Hefei 24
Seoul 24
Shenzhen 24
Brussels 20
Rome 20
Helsinki 19
Kent 19
Warsaw 19
Bitonto 18
Cangzhou 18
Da Nang 18
São Paulo 18
Haikou 16
Redwood City 16
Zhengzhou 16
Fuzhou 14
Hamburg 14
Ningbo 13
Stockholm 13
Jiaxing 12
Paris 12
Jakarta 11
San Diego 11
Berlin 10
Kunming 10
Surrey 10
Auburn Hills 9
Chicago 9
Dhaka 9
Hangzhou 9
Mumbai 9
Roxbury 9
Taiyuan 9
Turku 9
Chennai 8
Grafing 8
Kuala Lumpur 8
Saint Petersburg 8
Totale 8.346
Salva come PNG Salva come JPEG
Nome #
Effetti clinici della melatonina nei pazienti critici ad alto rischio 429
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm 336
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation 304
Pharmacokinetics of orally administered melatonin in critically ill patients 303
Melatonin reduces the need for sedation in ICU patients : a randomized controlled trial 295
Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems 291
La melatonina riduce la necessità di sedativi e di analgesici in pazienti critici ad alto rischio 291
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands 285
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN) 266
Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia 250
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling 227
Redox balance in patients with Down's syndrome before and after dietary supplementation with α-lipoic acid and L-cysteine 227
Bactericidal kinetics of an in vitro infection model of once-daily ceftriaxone plus amikacin against gram-positive and gram-negative bacteria 222
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells 220
Terapia farmacologica dell'influenza e delle sue complicanze 218
The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells 216
Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients 210
Effect of antibiotics on bordetella pertussis adhering activity: hypothesis regarding mechanism of action 208
Penetration of amphotericin B in human lung tissue after single liposomal amphotericin B (AmBisome) infusion 206
Melatonin delivery in solid lipid nanoparticles : prevention of cyclosporine A induced cardiac damage 203
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin 202
Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists 201
Transdermal apomorphine permeation from microemulsions : a new treatment in Parkinson's disease 201
Human pharmacokinetics and distribution in various tissues of ceftriaxone 193
Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue 192
Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity 191
Erratum: The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells (European Journal of Pharmacology (2010) 641 (29-34)) 190
Influence of protein binding on the pharmacodynamics of ceftazidime or ceftriaxone against gram-positive and gram-negative bacteria in an in vitro infection model 189
Relation between lymphocyte subpopulations and pineal function in patients with early or metastatic cancer 188
Synthesis and biology of melatonin and related indole analogs 185
Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions 183
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands : requirements for subtype selectivity and intrinsic activity modulation 179
Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media 177
Aging and vestibular system: specific tests and role of melatonin in cognitive involvement 173
IN VITRO COMPARATIVE DYNAMICS OF MODIFIED RELEASE CLARITHROMYCIN AND OF AZITHROMYCIN 173
Synthesis and the biological activity of new melatonin dimeric derivatives 172
Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands 169
Evaluation of the immunostimulating activity of erythromycin in man 169
Ceftezole levels in serum, bronchial secretun and pulmonary tissue 168
Neuroendocrine, immunohistochemical, and ultrastructural study of pineal region tumors 167
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin 165
2-N-acylaminoalkylindoles : design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists 164
2-[125i]iodomelatonin binding in normal and neoplastic tissues 163
Ultradian chronomodulation by melatonin of a Placebo effect upon human killer cell activity 162
Compartimenti intracellulari batterici e distribuzione intra-cellulare dei chemioantibiotici 159
Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue 156
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765 : Comparison with melatonin and diazepam 155
Characterization and mapping of melatonin receptors in the brain of three mammalian species : rabbit, horse and sheep. A comparative in vitro binding study 155
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain 153
Changes in th circadian rhythm of ornithine decarboxylase in rat liver during chemical hepatocarcinogenesis 149
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease 146
The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease 146
Comparison of the rat pinealocyte ultrastructure with melatonin concentrations during daytime and at night 146
The diffusion of clarythromycin and roxithromycin into nasal mucosa, tonsil and lung in humans 145
Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands 141
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 140
Melatonin and immunity 139
Enhancement of ornithine decarboxylase activity in rat adenohypophysis after pinealectomy 137
2-[125I]iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides 137
Regulation of the androgen receptors in the harderian gland of the male Syrian hamster: influence of photoperiod, castration, and chronic melatonin treatment 133
Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand 132
Alpha-1 adrenoceptor involvement in the control of melatonin secretion in the golden hamster 132
NO-donor melatonin derivatives : synthesis and in vitro pharmacological characterization 131
Humoral and cellular immunoresponse of mice treated with pyrazole-carboxamide-4-amino (PCA). 125
Melatonin in patients with chronic tinnitus 123
The melatonin receptor in the human brain: cloning experiments and distribution studies 123
Failure of prazosin to mimic the effects of melatonin under in vivo and in vitro conditions 123
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease 120
Pineal gland and polyamines 119
Comparative study on the electrophysiological responses at thalamic level to different analgesic peptides 118
Symptomatic Spinal Degenerative Pathologies: Clinical Results with the Application of Conservative Biochemical Treatments 117
Melatonin reduces the need for sedation in ICU patients: A randomized controlled trial 115
Cytosolic androgen receptors in the neuroendocrine tissues of the golden hamster: influence of photoperiod and melatonin treatment 115
Treatment of symptomatic lumbar spinal degenerative pathologies by means of combined conservative biochemical treatments 115
Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease 113
Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache 112
Effects of pinealectomy on the circadian rhythms of the activities of polyamine biosynthetic decarboxylases and tyrosine adminotransferase in different organs of the rat 109
Endocrine regulation of thymic biosynthetic polyamine decarboxylases in adult rat 106
Pharmacokinetics and tissue distribution of miocamycin 87
Totale 14.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021390 0 0 0 0 0 0 0 0 0 0 283 107
2021/2022980 110 34 55 60 59 87 65 38 122 69 107 174
2022/20231.168 191 129 111 119 122 239 21 63 116 4 36 17
2023/2024607 25 61 31 48 157 19 13 20 8 42 69 114
2024/20251.776 71 176 36 207 162 57 21 202 79 160 157 448
2025/20263.608 441 227 459 301 369 286 564 192 347 271 151 0
Totale 14.095